Melanotan 2 (MT2)
Melanotan 2 (MT2)

£19.99

Add to basket This product has multiple variants. The options may be chosen on the product page

Melanotan 2 (MT2)

£19.99

  • UK Stock
  • Secure Payments
  • Discreet UK Delivery

Melanotan 2 (MT2) is a synthetic cyclic heptapeptide analogue of α-melanocyte-stimulating hormone, supplied as a lyophilised material for melanocortin-receptor and pigmentation-signalling research.

COMPLETE YOUR KIT

Bacteriostatic Water - 3ml
Bacteriostatic Water - 3ml

In stock

£3.99
GHK-Cu - 50mg
GHK-Cu - 50mg

In stock

£19.99
1 Vial
£19.99
1 Vial
£17.99 Save 10%
3 Vials
£16.99 Save 15%
5 Vials
£15.99 Save 20%

For in vitro laboratory research only.
Not for human or veterinary use. Not for diagnosis, treatment, cure, or prevention of any disease. No dosage, administration, or injection guidance is provided.

Melanotan 2 (MT2) is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone (α-MSH). It is supplied as a lyophilised research material for controlled studies of melanocortin-receptor activity, receptor selectivity and pigmentation signalling.

Research material only

This material is not supplied as an authorised medicine, treatment, cosmetic, tanning product, supplement or consumer product. It is not for human or veterinary use, consumption or administration, and is not intended to diagnose, treat, cure or prevent any disease.

Compound overview

CompoundMelanotan 2 (MT2)
Research classCyclic α-MSH analogue / melanocortin-receptor agonist
Reference structureAc-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2
Peptide lengthCyclic heptapeptide
Reference molecular massApproximately 1024.2 Da
FormLyophilised material

Research context

Melanotan 2 is a lactam-bridged cyclic analogue derived from the central melanocortin sequence of α-MSH. Published studies commonly describe it as a potent, non-selective melanocortin-receptor agonist and have examined receptor binding, cyclic-AMP-associated signalling and pigmentation responses in experimental models.

Research has also used MT2 to investigate other melanocortin receptor subtypes and biological systems. Those observations reflect the particular materials, doses and experimental conditions used by the cited authors. They do not establish the identity, purity, performance or suitability of the material supplied on this page and must not be interpreted as consumer or clinical claims.

Batch documentation

Independent analytical documentation is published where available for specific batches and variations. A result indicator appears only when a published record is available. Match the product, stated mass and batch identifier to the corresponding report before relying on any result.

View available Melanotan 2 lab results →

Supply and laboratory handling

  • Supplied in the vial size selected above.
  • Keep the sealed lyophilised vial dry and protected from direct light.
  • A cool, dry place, refrigerator or freezer may be used according to the intended storage duration and your laboratory’s validated procedure.
  • Use clean laboratory technique and equipment appropriate to the intended analytical method.
  • Follow the lot-specific documentation and your laboratory’s validated handling and storage procedures.
  • Avoid repeated temperature cycling and unnecessary exposure to moisture.

Where a batch document or supplier specification gives different instructions, the lot-specific document takes precedence.

Frequently asked questions

What is Melanotan 2?

Melanotan 2 is a synthetic lactam-bridged cyclic heptapeptide derived from an α-MSH sequence. It is studied as a non-selective melanocortin-receptor agonist in receptor-signalling and pigmentation models.

Is Melanotan 2 the same as Melanotan 1?

No. Melanotan 2 is a cyclic heptapeptide with broader melanocortin-receptor activity. Melanotan 1, also known as afamelanotide, is a different linear 13-amino-acid analogue.

Is this product an authorised medicine or tanning product?

No. It is supplied only as a laboratory research material and is not an authorised medicine, cosmetic or tanning product. It is not for human or veterinary use, consumption or administration.

Which vial sizes are available?

Current vial sizes, stock, pre-order status, pricing and any batch-documentation indicators are shown in the variation selector above.

Does every vial size have a published laboratory result?

No. Results are available only for the selected batches and variations marked with a result indicator. Always check that the product, stated mass and batch identifier match the report.

How should the material be stored?

Keep the sealed lyophilised material dry and protected from light. A cool, dry place, refrigerator or freezer may be used according to the intended storage duration and your laboratory’s validated procedure. Avoid repeated temperature cycling and moisture exposure. No universal shelf-life is stated unless it is supported by batch documentation.

Information reviewed: 29 August 2026.

Size

10mg

Batch-specific analytical documentation

Independent analytical results are published for selected Havoc Labs products, vial sizes and batches. The result attached to one variation must not be treated as evidence for a different size or batch.

  • Result available: a published report is available for the marked variation.
  • Test pending: a sample has been submitted, but no completed result is being claimed.
  • No indicator: no product-specific result is currently displayed for that variation.

Check the identifiers

Always match the compound, vial size and batch reference on the product to the corresponding laboratory record. Where the laboratory provides an independent verification facility, use it to confirm the report.

Browse published lab results →

Storage and stability

Storage requirements can vary by compound, physical form, intended storage duration and batch. Follow the lot-specific documentation and your laboratory’s validated procedure wherever these are available.

Form Suggested storage Important note
Sealed lyophilised material Keep in a cool, dry place, refrigerated at 2–8°C or frozen, as appropriate for the compound and intended storage period. Keep sealed, dry and protected from direct light. Follow compound- and batch-specific documentation and avoid repeated temperature cycling.
Reconstituted solution Refrigerate at 2–8°C unless the applicable laboratory protocol specifies otherwise. Stability depends on the preparation conditions, solvent, concentration, container and handling. No universal storage period is claimed.

No universal shelf-life is claimed

Do not assume a fixed expiry or prepared-solution storage period unless it is supported by relevant stability data or batch documentation. Where a lot-specific document gives different instructions, that document takes precedence.

Published research

The sources below provide compound-level context for Melanotan 2, including its cyclic structure, melanocortin-receptor pharmacology and use in experimental pigmentation, receptor-selectivity and analytical models.

  1. PubChem. Melanotan II — Compound Summary, CID 92432. Reference identifiers, cyclic structure, sequence, formula and computed molecular mass. View on PubChem ↗
  2. Dorr RT et al. Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study. Life Sciences, 1996. Early controlled research describing the lactam-bridged cyclic peptide and measured experimental responses. View on PubMed ↗
  3. Adan RA et al. Characterization of melanocortin receptor ligands on cloned brain melanocortin receptors and on grooming behavior in the rat. European Journal of Pharmacology, 1999. Receptor-affinity and potency research involving MT2 and related melanocortin ligands. View on PubMed ↗
  4. Hatziieremia S et al. A liquid chromatographic/tandem mass spectroscopic method for quantification of the cyclic peptide melanotan-II. Rapid Communications in Mass Spectrometry, 2007. Analytical-method research measuring MT2 in experimental samples. View on PubMed ↗
  5. Carotenuto A et al. CLIPSing Melanotan-II to discover multiple functionally selective hMCR agonists. Journal of Medicinal Chemistry, 2022. Modern structure–activity research comparing MT2-derived ligands across human melanocortin receptors. View on PubMed ↗

Literature is not batch evidence

Published literature describes the materials, participants, models, analytical methods and experimental conditions used by its authors. It does not establish the identity, purity, performance or suitability of the material supplied on this page. Confirm the product, stated mass and batch identifier against the applicable analytical documentation.